Zentalis Pharmaceuticals (ZNTL) Interest Expenses (2019 - 2021)

Zentalis Pharmaceuticals' quarterly Interest Expenses came in at $44000.0 in Q1 2021, up 266.67% quarter-over-quarter from $12000.0 in Q1 2019.

Zentalis Pharmaceuticals has reported Interest Expenses for 2 years, with the latest figure at $44000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 22,854.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -5.50 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 61,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -332,000.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.90 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 69.29 Mn
10 Zentalis Pharmaceuticals 280.35 Mn 280.35 Mn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2021 44,000.00
Mar 31, 2021 44,000.00
Mar 31, 2019 12,000.00
Mar 31, 2019 12,000.00